Future of Personalized Medicine Summit is a 2-day networking online event with revolutionary keynotes, case studies, and panel discussions. It brings together experts from the fields of Pharmaceutical, Biotechnology, Hospitals, and Academics to discuss how AI and Blockchain technologies are impacting the Future of Medicine. A one of a kind forum to benchmark, gain subject matter expertise & business intelligence by collaborating with industry leaders from the field of Engineering, Diagnostics, Bioinformatics, Drug Discovery, Therapies and more.
Precision medicine seeks to use genomic data to help provide the right treatment to the right patient at the right time. Next-generation sequencing technology allows for the rapid and accurate sequencing of many genes at once. This technology is becoming more common in oncology, though the clinical benefit of incorporating it into precision medicine strategies remains under significant debate.
With the development and improvement of new sequencing technology, next-generation sequencing (NGS) has been applied increasingly in cancer genomics research over the past decade. More recently, NGS has been adopted in clinical oncology to advance the personalized treatment of cancer. NGS is used to identify novel and rare cancer mutations, detect familial cancer mutation carriers, and provide a molecular rationale for appropriate targeted therapy. Compared to traditional sequencing, NGS holds many advantages, such as the ability to fully sequence all types of mutations for a large number of genes (hundreds to thousands) in a single test at a relatively low cost.
Next-generation sequencing (NGS) provides an effective, unbiased way to identify new coronavirus strains and other pathogens without prior knowledge of organisms. Growing concern over fast-spreading, novel variants of the SARS-CoV-2 coronavirus, such as the B.1.1.7 strain [UK] and B1.351 strain (S. Africa), highlights the need for more sequencing to detect mutations quickly and prevent the spread of new strains. Sequencing was used to identify the novel coronavirus causing COVID-19 (SARS-CoV-2) early in the outbreak. NGS continues to provide public health officials, vaccine and drug developers, and researchers with critical evidence, allowing labs to:
“ With the advent of genetic engineering the time required for the evolution of new species may literally collapse.” - Dee Hock
Innovative keynotes delivered by the industry's true heavyweights, covering practical challenges and subjects which are exclusively entailed in our agenda. Gain subject matter expertise, network, and collaborate to explore solutions that shed light on future business models impacting revenue inflows.
Futurista Start-up Elevate is a dedicated platform for Startups and VCs. We offer industry-specific startups a showcasing opportunity, enabling them to connect with corresponding VCs and Mentors. A win-win dynamic is created to attain the desired exposure for startups who are looking forward to scaling up their businesses.
A smart application will help you connect with key decision makers, share files, brainstorm ideas, and have a seamless networking experience. A comprehensive module covering the entire event, compiled for training purposes, to be made available post-conference, exclusively for the attendees.
Long Reads & Genome Structure
Single Cell Sequencing
Spatial Sequencing Technologies
Population Scale And Clinical Sequencing
Development of Companion Diagnostics
Targeted Gene Expression Profiling
Large Whole-Genome Sequencing
Small Whole-Genome Sequencing
Cell-Free Sequencing & Liquid Biopsy Analysis
Group Futurista's first event- Post-GDPR/The Future of Data Protection 2018 was held in Berlin on 8th & 9th of November. Cross-industrial representatives were invited along with advocates, techno-sociologists, researches, and government representatives
to draw a bigger picture of the global impact of GDPR on businesses, societies, and cultures across the world.
The event helped many businesses to be better prepared with GDPR and other tech regulations that needed to be enforced. The Futurista Start-up Elevate platform allowed start-ups like Hotshot to showcase their solutions and collaborate with industry-leading organizations.
Another feather in our cap- Future of Digital Onboarding and Customer Experience Summit which was held on the 11th & 12th of April 2019, in London.
The event brought together some of the key decision makers from the biggest organizations, innovative Start-ups, and Governments around the globe, to discuss the various challenges and explore best-practices to optimize Digital Onboarding, Customer Experience and Identity Management processes for financial institutions.
Along with all the benefits of the Standard Pass, get an early access to the attendee list that allows you to scope out the key profiles that you’d like to network with. This gives you a head start as you will have time to be prepared for the meetings
and achieve your key objectives.
These meetings are planned to help you meet your networking objectives with a dedicated space providing just the right atmosphere. An exclusive business lounge for you to set one-on-one meetings with the senior most delegates at the summit, fostering strategic business relationships and opportunities.
How will it work? Send your profile and a short message to the delegate that you’d like to set a meeting with. When or if the invites are accepted, the meeting is set in your respective calendars. Our event executives will make sure the meetings are set up seamlessly at the venue. Reach out to us for more information.